Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eaddy JS"'
Autor:
Mosedale M; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: merrie@unc.edu., Cai Y; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: ywcai@email.unc.edu., Eaddy JS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: jseaddy@gmail.com., Kirby PJ; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: patrick.kirby@dragonflytx.com., Wolenski FS; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: fwolenski@gmail.com., Dragan Y; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: yvonne.dragan@takeda.com., Valdar W; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: william.valdar@unc.edu.
Publikováno v:
Toxicology [Toxicology] 2021 Sep; Vol. 461, pp. 152902. Date of Electronic Publication: 2021 Aug 18.
Autor:
Church RJ; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Schomaker SJ; Pfizer Inc., Groton, Connecticut, United States of America., Eaddy JS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Boucher GG; Pfizer Inc., Groton, Connecticut, United States of America., Kreeger JM; Pfizer Inc., Groton, Connecticut, United States of America., Aubrecht J; Pfizer Inc., Groton, Connecticut, United States of America., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Oct 09; Vol. 15 (10), pp. e0240562. Date of Electronic Publication: 2020 Oct 09 (Print Publication: 2020).
Autor:
Mosedale M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Cai Y; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Department of Genetics., Eaddy JS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Corty RW; Department of Genetics., Nautiyal M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Valdar W; Department of Genetics.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2019 Dec 01; Vol. 172 (2), pp. 265-278.
Autor:
Mosedale M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Eaddy JS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Trask OJ Jr; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Holman NS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599.; Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Wolf KK; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; QPS DMPK Hepatic Biosciences, Research Triangle Park, North Carolina 27709., LeCluyse E; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Ware BR; School of Biomedical Engineering, Colorado State University, Fort Collins, Colorado 80523.; Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois 60607., Khetani SR; Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois 60607., Lu J; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Brock WJ; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, Maryland 20850.; Brock Scientific Consulting, Montgomery Village, Maryland 20886., Roth SE; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, Maryland 20850., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Jan 01; Vol. 161 (1), pp. 149-158.
Autor:
Mosedale M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Kim Y; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599., Brock WJ; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland 20850.; Brock Scientific Consulting, Montgomery Village, Maryland 20886., Roth SE; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland 20850., Wiltshire T; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599.; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599., Eaddy JS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Keele GR; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599., Corty RW; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599., Xie Y; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599., Valdar W; Department of Genetics, UNC School of Medicine, Chapel Hill, North Carolina 27599.; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2017 Apr 01; Vol. 156 (2), pp. 438-454.
Autor:
Church RJ; Hamner-UNC Institute for Drug Safety Sciences, Durham, NC 27709, USA., Gatti DM; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Urban TJ; Duke University, Durham, NC 27708, USA., Long N; Duke University, Durham, NC 27708, USA., Yang X; U.S. Food and Drug Administration National Center for Toxicological Research, Jefferson, AR 72079, USA., Shi Q; U.S. Food and Drug Administration National Center for Toxicological Research, Jefferson, AR 72079, USA., Eaddy JS; Hamner-UNC Institute for Drug Safety Sciences, Durham, NC 27709, USA., Mosedale M; Hamner-UNC Institute for Drug Safety Sciences, Durham, NC 27709, USA., Ballard S; North Carolina State University, Raleigh, NC 27607, USA., Churchill GA; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Navarro V; Einstein Healthcare Network, Philadelphia, PA 19141, USA., Watkins PB; Hamner-UNC Institute for Drug Safety Sciences, Durham, NC 27709, USA., Threadgill DW; North Carolina State University, Raleigh, NC 27607, USA., Harrill AH; Hamner-UNC Institute for Drug Safety Sciences, Durham, NC 27709, USA. Electronic address: ahharrill@uams.edu.
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2015 Feb; Vol. 76, pp. 19-26. Date of Electronic Publication: 2014 Nov 28.
Autor:
Church RJ; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709 ahharrill@uams.edu., Wu H; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, Connecticut 06340 ahharrill@uams.edu., Mosedale M; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709 ahharrill@uams.edu., Sumner SJ; Discovery Sciences, RTI International, Research Triangle Park, North Carolina 27709., Pathmasiri W; Discovery Sciences, RTI International, Research Triangle Park, North Carolina 27709., Kurtz CL; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709., Pletcher MT; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, Connecticut 06340., Eaddy JS; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709., Pandher K; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, Connecticut 06340., Singer M; Janssen Research and Development, Drug Safety Sciences, Raritan, New Jersey 08869., Batheja A; Janssen Research and Development, Drug Safety Sciences, Raritan, New Jersey 08869., Watkins PB; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709 Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Adkins K; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, Connecticut 06340 ahharrill@uams.edu., Harrill AH; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709 Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 The University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 ahharrill@uams.edu.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2014 Aug 01; Vol. 140 (2), pp. 481-92. Date of Electronic Publication: 2014 May 20.
Autor:
Harrill AH; College of Public Health, The University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; The Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: ahharrill@uams.edu., Eaddy JS; The Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA., Rose K; The Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA., Cullen JM; College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA., Ramanathan L; QPS, Newark, DE 19711, USA., Wanaski S; NeuroTherapeutics Pharma, Inc., Chicago, IL 60631, USA., Collins S; NeuroTherapeutics Pharma, Inc., Chicago, IL 60631, USA., Ho Y; NeuroTherapeutics Pharma, Inc., Chicago, IL 60631, USA., Watkins PB; The Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA; Schools of Pharmacy and Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Lecluyse EL; The Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2014 Jun 01; Vol. 277 (2), pp. 131-7. Date of Electronic Publication: 2014 Mar 31.
Autor:
Harrill AH; The Hamner Institutes for Health Sciences, Hamner-University of North Carolina Institute for Drug Safety Sciences, Durham, North Carolina 27709, USA. aharrill@thehamner.org, Desmet KD, Wolf KK, Bridges AS, Eaddy JS, Kurtz CL, Hall JE, Paine MF, Tidwell RR, Watkins PB
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2012 Dec; Vol. 130 (2), pp. 416-26. Date of Electronic Publication: 2012 Aug 31.
Autor:
Harrill AH; Hamner-University of North Carolina Institute for Drug Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC, USA., Roach J, Fier I, Eaddy JS, Kurtz CL, Antoine DJ, Spencer DM, Kishimoto TK, Pisetsky DS, Park BK, Watkins PB
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2012 Aug; Vol. 92 (2), pp. 214-20. Date of Electronic Publication: 2012 Jun 27.